Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jan;15(1):45-56.
doi: 10.1038/nri3790.

Clinical blockade of PD1 and LAG3--potential mechanisms of action

Affiliations
Review

Clinical blockade of PD1 and LAG3--potential mechanisms of action

Linh T Nguyen et al. Nat Rev Immunol. 2015 Jan.

Abstract

Dysfunctional T cells can render the immune system unable to eliminate infections and cancer. Therapeutic targeting of the surface receptors that inhibit T cell function has begun to show remarkable success in clinical trials. In this Review, we discuss the potential mechanisms of action of the clinical agents that target two of these receptors, programmed cell death protein 1 (PD1) and lymphocyte activation gene 3 protein (LAG3). We also suggest correlative studies that may define the predominant mechanisms of action and identify predictive biomarkers.

PubMed Disclaimer

References

    1. Nature. 2014 Nov 27;515(7528):563-7 - PubMed
    1. N Engl J Med. 2013 Jul 11;369(2):122-33 - PubMed
    1. Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10468-73 - PubMed
    1. PLoS One. 2012;7(2):e30852 - PubMed
    1. Eur J Immunol. 2005 Jul;35(7):2081-8 - PubMed

MeSH terms